Home › Asset managers › Compare 2023-2024 › John Hancock vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 11.4% of the 112,275 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
John Hancock 2023-2024 · Brighthouse 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 24,203 | 18,385 | 891 | 4,927 | 95.4% | 88.3% |
| Board proposals | 20,526 | 15,644 | 853 | 4,029 | 94.8% | 88.5% |
| E&S shareholder proposals | 328 | 17 | 6 | 305 | 73.9% | 36.0% |
| Other items | 3,349 | 2,724 | 32 | 593 | 98.8% | 92.4% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
4,882 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | John Hancock | Brighthouse |
|---|---|---|---|---|---|---|
| VIZIO HOLDING CORP. | June 12, 2024 | Election of Directors: John R. Burbank Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 1 fund |
| VIZIO HOLDING CORP. | June 12, 2024 | Election of Directors: William Wang Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 1 fund |
| VMWARE INC. | July 13, 2023 | To ratify the selection by the Audit Committee of Vmware's Board of Directors of PricewaterhouseCoopers LLP as Vmware's independent auditor for the fiscal year ending February 2, 2024. Audit-related |
Board | For | FOR 3 funds |
ABSTAIN 1 fund |
| VOR BIOPHARMA INC. | May 23, 2024 | To approve the amendment and restatement of the Vor Biopharma Inc. 2021 Equity Incentive Plan to, among other things, increase the number of shares that will automatically be added to the share reserve thereunder on January 1 of each calendar year from four percent (4%) to five percent (5%) of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year through and including calendar year 2034. Compensation |
Board | For | AGAINST 2 funds |
ABSTAIN 1 fund |
| VOR BIOPHARMA INC. | May 23, 2024 | To ratify the selection by the audit committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Audit-related |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| WALT DISNEY CO. | April 3, 2024 | Company Recommended Nominee: Carolyn N. Everson Director Elections |
Board | Contested | FOR 9 funds |
WITHHOLD 2 funds |
| WALT DISNEY CO. | April 3, 2024 | Company Recommended Nominee: Maria Elena Lagomasino Director Elections |
Board | Contested | FOR 9 funds |
WITHHOLD 2 funds |
| WALT DISNEY CO. | April 3, 2024 | Company Recommended Nominee: Mark G. Parker Director Elections |
Board | Contested | FOR 9 funds |
WITHHOLD 2 funds |
| WALT DISNEY CO. | April 3, 2024 | Company Recommended Nominee: Mary T. Barra Director Elections |
Board | Contested | FOR 9 funds |
WITHHOLD 2 funds |
| WARBY PARKER INC. | June 7, 2024 | Election of Directors: Andrew Hunt Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 1 fund |
| WARBY PARKER INC. | June 7, 2024 | Election of Directors: Gabrielle Sulzberger Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 1 fund |
| WATTS WATER TECHNOLOGIES INC. | May 22, 2024 | Election of Directors: David A. Dunbar Director Elections |
Board | For | ABSTAIN 6 funds |
WITHHOLD 7 funds |
| WATTS WATER TECHNOLOGIES INC. | May 22, 2024 | Election of Directors: Joseph W. Reitmeier Director Elections |
Board | For | ABSTAIN 6 funds |
WITHHOLD 7 funds |
| WATTS WATER TECHNOLOGIES INC. | May 22, 2024 | Election of Directors: Louise K. Goeser Director Elections |
Board | For | ABSTAIN 6 funds |
WITHHOLD 7 funds |
| WATTS WATER TECHNOLOGIES INC. | May 22, 2024 | Election of Directors: Merilee Raines Director Elections |
Board | For | ABSTAIN 6 funds |
WITHHOLD 7 funds |
| WATTS WATER TECHNOLOGIES INC. | May 22, 2024 | Election of Directors: Michael J. Dubose Director Elections |
Board | For | ABSTAIN 6 funds |
WITHHOLD 7 funds |
| WEATHERFORD INTERNATIONAL PLC | June 12, 2024 | Election of Director: Benjamin C. Duster, IV Director Elections |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| WEATHERFORD INTERNATIONAL PLC | June 12, 2024 | Election of Director: Charles M. Sledge Director Elections |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| WEATHERFORD INTERNATIONAL PLC | June 12, 2024 | Election of Director: Girishchandra K. Saligram Director Elections |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| WEATHERFORD INTERNATIONAL PLC | June 12, 2024 | Election of Director: Jacqueline C. Mutschler Director Elections |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| WEATHERFORD INTERNATIONAL PLC | June 12, 2024 | Election of Director: Neal P. Goldman Director Elections |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| WEIS MARKETS INC. | May 2, 2024 | Election of Directors: Dennis G. Hatchell Director Elections |
Board | For | ABSTAIN 4 funds |
WITHHOLD 1 fund |
| WEIS MARKETS INC. | May 2, 2024 | Election of Directors: Edward J. Lauth III Director Elections |
Board | For | ABSTAIN 4 funds |
WITHHOLD 1 fund |
| WEIS MARKETS INC. | May 2, 2024 | Election of Directors: Gerrald B. Silverman Director Elections |
Board | For | ABSTAIN 4 funds |
WITHHOLD 1 fund |
| WEIS MARKETS INC. | May 2, 2024 | Election of Directors: Harold G. Graber Director Elections |
Board | For | ABSTAIN 4 funds |
WITHHOLD 1 fund |
| WEIS MARKETS INC. | May 2, 2024 | Election of Directors: Jonathan H. Weis Director Elections |
Board | For | ABSTAIN 4 funds |
WITHHOLD 1 fund |
| WELL HEALTH TECHNOLOGIES CORP. | June 12, 2024 | Elect Director Hamed Shahbazi Director Elections |
Board | For | ABSTAIN 1 fund |
WITHHOLD 1 fund |
| WESTLAKE CORP. | May 9, 2024 | Election of Class II Directors: James Y. Chao Director Elections |
Board | Not determined | ABSTAIN 5 funds |
WITHHOLD 3 funds |
| WESTLAKE CORP. | May 9, 2024 | Election of Class II Directors: John T. Chao Director Elections |
Board | Not determined | ABSTAIN 5 funds |
WITHHOLD 3 funds |
| WESTSHORE TERMINALS INVESTMENT CORP. | June 18, 2024 | Elect Director Brian Canfield Director Elections |
Board | For | ABSTAIN 2 funds |
WITHHOLD 1 fund |
| WESTSHORE TERMINALS INVESTMENT CORP. | June 18, 2024 | Elect Director Clark H. Hollands Director Elections |
Board | For | ABSTAIN 2 funds |
WITHHOLD 1 fund |
| WESTSHORE TERMINALS INVESTMENT CORP. | June 18, 2024 | Elect Director William W. Stinson Director Elections |
Board | For | ABSTAIN 2 funds |
WITHHOLD 1 fund |
| WNS (HOLDINGS) LTD. | June 27, 2024 | Re-appointment of Grant Thornton Bharat LLP as the auditors of the Company Audit-related |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| WNS (HOLDINGS) LTD. | June 27, 2024 | Re-election of the Class III Director, Mr. Jason Liberty Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| WNS (HOLDINGS) LTD. | June 27, 2024 | Re-election of the Class III Director, Ms. Judy Marlinski Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| WUXI BIOLOGICS (CAYMAN) INC. | June 19, 2024 | TO RE-ELECT MR. WILLIAM ROBERT KELLER AS INDEPENDENT NON-EXECUTIVE DIRECTOR Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| XENON PHARMACEUTICALS INC. | June 4, 2024 | Amendment to the Amended and Restated 2014 Plan: Approve certain amendments to the Amended and Restated 2014 Equity Incentive Plan, including to increase the maximum number of Common Shares available for issuance thereunder by 5,200,000 Compensation |
Board | For | FOR 3 funds |
ABSTAIN 2 funds |
| XENON PHARMACEUTICALS INC. | June 4, 2024 | Appointment of Auditor: Appoint KPMG LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation or until their successors are duly elected Audit-related |
Board | For | FOR 3 funds |
WITHHOLD 2 funds |
| XENON PHARMACEUTICALS INC. | June 4, 2024 | Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporations named executive officers Say-on-Pay |
Board | For | FOR 3 funds |
ABSTAIN 2 funds |
| XENON PHARMACEUTICALS INC. | June 4, 2024 | Remuneration of Auditor: Authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditor of the Corporation Audit-related |
Board | For | FOR 3 funds |
ABSTAIN 2 funds |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Johan Wedell-Wedellsborg Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 4 funds |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Thomas Gad Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 4 funds |
| YETI HOLDINGS INC. | May 7, 2024 | Election of two Class III directors: Alison Dean Director Elections |
Board | For | ABSTAIN 5 funds |
WITHHOLD 2 funds |
| YEXT INC. | June 12, 2024 | Election of Class I Directors: Julie Richardson Director Elections |
Board | For | ABSTAIN 4 funds |
WITHHOLD 2 funds |
| ZAI LAB LTD. | June 18, 2024 | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ZIPRECRUITER INC. | June 11, 2024 | Election of Class III Directors for three-year term: Blake Irving Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 1 fund |
| ZIPRECRUITER INC. | June 11, 2024 | Election of Class III Directors for three-year term: Emily McEvilly Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 1 fund |
| ZOOM VIDEO COMMUNICATIONS INC. | June 13, 2024 | Elect three nominees for Class II director to serve until our 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jonathan Chadwick Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 2 funds |
| ZOOMINFO TECHNOLOGIES INC. | May 15, 2024 | To elect the director nominees listed in the Proxy Statement: Henry Schuck Director Elections |
Board | For | ABSTAIN 5 funds |
WITHHOLD 8 funds |
| ZOOMINFO TECHNOLOGIES INC. | May 15, 2024 | To elect the director nominees listed in the Proxy Statement: Keith Enright Director Elections |
Board | For | ABSTAIN 5 funds |
WITHHOLD 8 funds |
| ZUORA INC. | June 27, 2024 | To elect Kenneth A. Goldman, Joseph Osnoss, and Tien Tzuo to serve as Class III directors until our 2027 annual meeting of stockholders and until such director's successor is duly elected and qualified or until his earlier death, resignation, disqualification or removal: Kenneth A. Goldman Director Elections |
Board | For | ABSTAIN 4 funds |
WITHHOLD 4 funds |
| ZYMEWORKS INC. | December 7, 2023 | Election of Directors: Hollings C. Renton Director Elections |
Board | For | ABSTAIN 3 funds |
WITHHOLD 2 funds |
| ZYNEX INC. | May 16, 2024 | Election of Directors: Joshua R. Disbrow Director Elections |
Board | For | ABSTAIN 2 funds |
WITHHOLD 1 fund |
| 1-800 FLOWERS.COM INC. | December 14, 2023 | To approve, on an advisory basis, the Company's executive compensation for its named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| 1-800-FLOWERS.COM INC. | December 14, 2023 | To approve an amendment to the 2003 Long Term Incentive and Share Award Plan to increase the authorized shares. Compensation |
Board | For | FOR 4 funds |
Split 1 FOR, 1 ABSTAIN |
| 1-800-FLOWERS.COM INC. | December 14, 2023 | To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending June 30, 2024. Audit-related |
Board | For | FOR 4 funds |
Split 1 FOR, 1 ABSTAIN |
| 10X GENOMICS INC. | June 11, 2024 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; and Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 1 FOR, 3 AGAINST |
| 10X GENOMICS INC. | June 11, 2024 | Election of Directors: Election of the one Class II director listed in the accompanying proxy statement, to serve a three-year term expiring at the 2027 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal; Kimberly J. Popovits Director Elections |
Board | For | AGAINST 5 funds |
Split 1 FOR, 3 AGAINST |
| 1ST SOURCE CORP. | April 25, 2024 | Election of Directors for terms expiring April 2027 Mark D. Schwabero Director Elections |
Board | For | Split 2 FOR, 6 AGAINST |
FOR 1 fund |
| 1ST SOURCE CORP. | April 25, 2024 | Election of Directors for terms expiring April 2027 Ronda Shrewsbury Director Elections |
Board | For | Split 2 FOR, 6 AGAINST |
FOR 1 fund |
| 2SEVENTY BIO INC. | June 10, 2024 | Election of Class III Directors: Denice Torres Director Elections |
Board | For | ABSTAIN 3 funds |
Split 1 FOR, 1 WITHHOLD |
| 2SEVENTY BIO INC. | June 10, 2024 | Election of Class III Directors: Marcela Maus, MD, PhD Director Elections |
Board | For | ABSTAIN 3 funds |
Split 1 FOR, 1 WITHHOLD |
| 3M CO. | May 14, 2024 | Advisory approval of executive compensation. Say-on-Pay |
Board | For | AGAINST 1 fund |
Split 1 FOR, 4 AGAINST, 1 ABSTAIN |
| A. O. SMITH CORP. | April 9, 2024 | Election of directors: Christopher L. Mapes Director Elections |
Board | For | Split 4 FOR, 2 ABSTAIN |
FOR 6 funds |
| A. O. SMITH CORP. | April 9, 2024 | Election of directors: Michael M. Larsen Director Elections |
Board | For | Split 4 FOR, 2 ABSTAIN |
FOR 6 funds |
| A. O. SMITH CORP. | April 9, 2024 | Proposal to approve, by nonbinding advisory vote, the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 6 funds |
Split 1 AGAINST, 5 ABSTAIN |
| A. O. SMITH CORP. | April 9, 2024 | Proposal to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the corporation: Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 1 AGAINST, 5 ABSTAIN |
| AAR CORP. | September 19, 2023 | Approve an amendment to our stock plan Compensation |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| AAR CORP. | September 19, 2023 | Ratify the appointment of KPMG LLP as our independent registered public accounting firm for Fiscal 2024 Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| AARON'S COMPANY INC. | May 15, 2024 | Approval, on a non-binding, advisory basis, of the Company's named executive officer compensation. Say-on-Pay |
Board | For | Split 4 FOR, 1 AGAINST |
FOR 2 funds |
| AB SAGAX | May 8, 2024 | APPROVE ISSUANCE OF UP TO 10 PERCENT OF SHARE CAPITAL WITHOUT PREEMPTIVE RIGHTS Capital Structure |
Board | For | Split 1 FOR, 3 AGAINST |
AGAINST 3 funds |
| AB SAGAX | May 8, 2024 | APPROVE REMUNERATION POLICY AND OTHER TERMS OF EMPLOYMENT FOR EXECUTIVE MANAGEMENT Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 3 funds |
| AB SAGAX | May 8, 2024 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | Split 2 FOR, 2 AGAINST |
AGAINST 3 funds |
| AB SAGAX | May 8, 2024 | REELECT FILIP ENGELBERT AS DIRECTOR Director Elections |
Board | For | Split 1 FOR, 3 AGAINST |
AGAINST 3 funds |
| AB SAGAX | May 8, 2024 | REELECT JOHAN CEDERLUND AS DIRECTOR Director Elections |
Board | For | Split 1 FOR, 3 AGAINST |
AGAINST 3 funds |
| AB SAGAX | May 8, 2024 | REELECT ULRIKA WERDELIN AS DIRECTOR Director Elections |
Board | For | Split 1 FOR, 3 AGAINST |
AGAINST 3 funds |
| ABBOTT LABORATORIES | April 26, 2024 | Ratification of Ernst & Young LLP As Auditors Audit-related |
Board | For | FOR 11 funds |
Split 9 FOR, 1 ABSTAIN |
| ABBOTT LABORATORIES | April 26, 2024 | Say on Pay - An Advisory Vote on the Approval of Executive Compensation Say-on-Pay |
Board | For | FOR 14 funds |
Split 7 FOR, 1 AGAINST, 1 ABSTAIN |
| ABBVIE INC. | May 3, 2024 | Election of Class III Directors Glenn F. Tilton Director Elections |
Board | For | Split 12 FOR, 2 AGAINST |
FOR 1 fund |
| ABBVIE INC. | May 3, 2024 | Election of Class III Directors Rebecca B. Roberts Director Elections |
Board | For | Split 12 FOR, 2 AGAINST |
FOR 1 fund |
| ABBVIE INC. | May 3, 2024 | Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay |
Board | For | FOR 17 funds |
Split 10 FOR, 6 ABSTAIN |
| ABM INDUSTRIES INC. | March 27, 2024 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 1 fund |
Split 4 FOR, 2 ABSTAIN |
| ABM INDUSTRIES INC. | March 27, 2024 | Election of Directors Art A. Garcia Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| ACADIA HEALTHCARE COMPANY INC. | May 23, 2024 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 12 funds |
Split 6 FOR, 2 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement. Say-on-Pay |
Board | For | FOR 8 funds |
Split 6 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2024 | To elect three Class II directors to hold office until the Company's 2027 Annual Meeting of Stockholders: Julian C. Baker Director Elections |
Board | For | Split 4 FOR, 2 WITHHOLD |
Split 5 FOR, 2 WITHHOLD |
| ACADIA PHARMACEUTICALS INC. | May 29, 2024 | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 2, 2024 | THE APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPANY'S 2024 PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 8 funds |
Split 3 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 2, 2024 | THE RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024. Audit-related |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ACCEL ENTERTAINMENT INC. | May 9, 2024 | Non-binding advisory vote on the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
Split 4 FOR, 1 ABSTAIN |
| ACCEL ENTERTAINMENT INC. | May 9, 2024 | Ratify the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| ACCENTURE PLC | January 31, 2024 | To approve the Amended and Restated Accenture plc 2010 Employee Share Purchase Plan to increase the number of shares available for issuance and make other amendments. Compensation |
Board | For | FOR 14 funds |
Split 6 FOR, 2 AGAINST |
| ACCENTURE PLC | January 31, 2024 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan to increase the number of shares available for issuance thereunder. Compensation |
Board | For | Split 13 FOR, 1 AGAINST |
Split 6 FOR, 2 ABSTAIN |
| ACCENTURE PLC | January 31, 2024 | To approve, in a non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 5 FOR, 1 AGAINST, 2 ABSTAIN |
| ACCENTURE PLC | January 31, 2024 | To determine the price range at which Accenture can re-allot shares that it acquires as treasury shares under Irish law. Capital Structure |
Board | For | FOR 14 funds |
Split 11 FOR, 2 ABSTAIN |
| ACCENTURE PLC | January 31, 2024 | To grant the Board of Directors the authority to opt-out of pre-emption rights under Irish law. Capital Structure |
Board | For | FOR 14 funds |
Split 6 FOR, 2 AGAINST |
| ACI WORLDWIDE INC. | June 4, 2024 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2024; Audit-related |
Board | For | FOR 6 funds |
Split 3 FOR, 3 ABSTAIN |
| ACUITY BRANDS INC. | January 24, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| ACV AUCTIONS INC. | May 29, 2024 | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024, and Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ADAPTIVE BIOTECHNOLOGIES CORP. | June 7, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | FOR 4 funds |
Split 5 FOR, 1 ABSTAIN |
← Previous Page 9 of 49 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.